Our
Clients
: Aug, 2020
: 100
:
Global Cancer Biomarkers Market Analysis by cancer type, biomarker type, application, profiling technology, Region and segments forecast till 2033
Market Overview
The Global Cancer biomarkers market size was USD 10,690 million in 2022, and is anticipated to grow to a value of more than USD 32,090 million by 2033, with a growing CAGR (compound annual growth rate) of over 13% from 2023 to 2033.
Report Scope
Report Attributes | Description |
Market Forecast in 2022 | USD 10,690 million |
Market Forecast in 2033 | USD 32,090 million |
CAGR % 2023-2033 | 13% |
Base Year | 2022 |
Historic Data | 2020-2021 |
Forecast Period | 2023-2033 |
Report USP | Product, end-user industry, company share, company heatmap, company Capacity Technology Product capacity, growth factors and more |
Key Companies | F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., QIAGEN N.V., Illumina Inc., Bio-Rad Laboratories Inc., Abbott Laboratories, Exact Sciences, Meso Scale Diagnostics LLC, Seegene Technologies Inc., and Siemens Healthineers. |
Global Cancer Biomarkers Market- Description
Cancer biomarkers are natural particles that propose the presence of cancer in a patient. They are either delivered by the cancer cells or by noncancer cells in light of cancer. Cancer biomarkers distinguished from serum are for the most part beneficial type of the biomarkers that can be utilized for customized daily care in screening, diagnosis, establishing prognosis, observing treatment, and identifying backslide.
The cancer biomarkers are utilized in the diagnosis and therapy pertaining to the disease. One of the noticeable elements driving the development of the worldwide cancer biomarkers market is rising rates of cancer from one side of the world to the other. As per the World Health Organization (WHO), cancer is one of the major reason for death globally, with roughly 10 million fatalities expected in 2020, which is almost one in each six deaths. The most frequent cancer forms are cellular breakdown in the lungs, breast cancer, rectum cancer, and prostate cancer. Because of this large number of cancers, the improvement of cancer biomarkers has become need on the lookout.
Another element driving the development of the worldwide cancer biomarkers market is rising geriatric populace. The elderly individuals are more inclined to perilous issues like cancer. In this manner, these individuals require extreme attention to detail and speedy treatment against such infections. Additionally, the technological progressions are additionally making development possibilities for the extension of the worldwide cancer biomarkers market. Hence, the reception of creative technologies is assisting to develop novel cancer biomarkers in the worldwide market.
Global Cancer biomarkers Market: Key trends
Rising innovative progressions in the advancement of cancer biomarkers
The headways in clusters and proteomics innovations have tended to the difficulties in distinguishing and grasping the capacities and interactions of different proteins. These technological headways have worked on the course of disclosure and improvement of novel cancer biomarkers to a great extent.
Customized medication
Customized medication distinguishes the most advantageous treatment way for individual patients. Cancer biomarkers assume a vital part in specific parts of customized medication. Consumables utilized in cancer biomarker testing empower the identification proof of these illnesses. Cancer biomarker indicative items are likewise utilized as sidekick diagnostics for a long-time treatment. Accordingly, the field of customized medication is supposed to offer potential learning experiences for players working in the cancer biomarkers market.
Specialized issues connected with test assortment
Sample assortment is one of the main points of contention for specialist organizations, trailed by admittance to these examples. Rigid quality control of these examples is required, and they should be put away under the right circumstances to keep away from any misfortune. Additionally, various examples are expected for risk recognition, screening, determination, and observing cycles.
Global Cancer biomarkers Market: Segment Analysis
Global Cancer biomarkers Market based by cancer type
Breast Cancer
Lung Cancer
Prostate Cancer
Colorectal Cancer
Blood Cancer
Melanoma
Ovarian Cancer
Liver Cancer
Stomach Cancer
Breast cancer segment dominates the market with the largest market share.
Global Cancer biomarkers market based by biomarker type
Genetic biomarkers
Protein biomarkers
Protein biomarkers hold the largest market among others of the cancer biomarkers market.
Global Cancer biomarkers market based by application
Drug discovery and development
Personalised medicine
Diagnostics
Diagnostics segment represented for the largest share in the cancer biomarkers market.
Global Cancer biomarkers market based by profiling technology
Imaging technologies
Omic Technologies -Proteomics, Genomics, and Other Omic technologies
Cytogenetics-Based Tests
Immunoassays
Omics technologies segment accounted for the largest market share in the cancer biomarkers market.
Global Cancer Biomarkers Market by region
In term of geographic region, the Global Cancer Biomarkers Market is divided into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The Asia-pacific dominates the market with the highest market share.
Global Cancer Biomarkers Market- Recent Developments
In March 2023, Roche announced that its FDA-approved CancerSEEK test for multiple cancer types is now available for commercial use in the United States. CancerSEEK is a liquid biopsy test that uses a combination of biomarkers to detect cancer at early stages.
In February 2023, Thermo Fisher Scientific announced that it had acquired QIAGEN, a leading provider of molecular diagnostic and cancer biomarker solutions, for $11.5 billion. The acquisition is expected to strengthen Thermo Fisher's position in the cancer diagnostics market and expand its offerings in the molecular diagnostics segment.
Global Cancer Biomarkers Market: Company Profiles
F. Hoffmann-La Roche Ltd.
Thermo Fisher Scientific Inc.
QIAGEN N.V.
Illumina Inc.
Bio-Rad Laboratories Inc.
Abbott Laboratories
Exact Sciences
Meso Scale Diagnostics LLC
Seegene Technologies Inc.
Siemens Healthineers.
Others
Global Cancer Biomarkers Market: Regional Scope
North America
U.S.
Canada
Mexico
Europe
U.K.
Germany
France
Italy
Spain
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Rest of Asia Pacific
South America
Brazil
Argentina
Rest of South America
Middle East and Africa
Saudi Arabia
UAE
Egypt
South Africa
Rest of Middle East and Africa
Why to buy this Report?
Market research: The report provides valuable insights into market trends, growth opportunities, and competitive landscapes. By reading a technology report, businesses and investors can gain a better understanding of the market they are operating in or considering entering, and make more informed decisions based on data and analysis.
Competitive analysis: The report reports provide detailed information on competitors' strengths, weaknesses, and strategies, which can help businesses identify potential threats and opportunities in the market.
Innovation: The report provides insights into emerging technologies and trends, which can help businesses stay up-to-date with the latest developments and make informed decisions about where to invest their resources.
Due diligence: The report can be used by investors and acquirers as part of their due diligence process when considering investing in or acquiring a technology company. These reports can provide valuable information on the company's financials, technology, market position, and other key factors.
Frequently Asked Questions
What is the market size and growth projections?
What is the market size and growth projection for each of the market segments and sub-segments across Countries & Regions?
What are the top performing segments, and countries / regions of each of the markets?
What is the market size and growth rate across key countries / regions?
How big is the global & regional market in terms of revenue and volume?
How far market will grow in forecast period in terms of revenue and volume?
What factors will influence demand and supply trends across each markets during the forecast period?
What are the technology trends shaping various markets?
Which country / region has more opportunities?
What is the COVID-19 impact on the market and how long will it take to recover?
Who are the key competitors of market Players?
What are the market share (%) of Key Players?
What are the Merger & Acquisition, New Product Launch, Recent Development within each of the Markets?
What are PEST analysis, Ecosystem Analysis, Porter's Five Forecast Analysis, Ansoff Matrix, and SWOT Analysis among other analyses for diverse markets?
1. Global CANCER BIOMARKERS Market Introduction and Market Overview
1.1. Objective of the Market Research Study
1.2. CANCER BIOMARKERS Market Definition & Description
1.3. Research Data Parameters & Reporting Timelines
1.3.1. Historical Data Reporting Years 2020 to 2021
1.3.2. Projected Data Reporting Years 2022 to 2033
1.3.3. Reporting Data Parameters Value (US$ Million)
1.4. Global CANCER BIOMARKERS Market Scope and Market Estimation
1.4.1. Global CANCER BIOMARKERS Overall Market Size (US$ Million), Market CAGR (%), Market Estimates & Forecast (2020 to 2033)
1.4.2. Global CANCER BIOMARKERS Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2020 to 2033
1.5. CANCER BIOMARKERS Market Segmentation
1.5.1. Biomarkers Type of Global CANCER BIOMARKERS Market
1.5.2. Cancer Type of Global CANCER BIOMARKERS Market
1.5.3. Profiling Technologies of Global CANCER BIOMARKERS Market
1.5.4. Application of Global CANCER BIOMARKERS Market
1.5.5. Key Regions of Global CANCER BIOMARKERS Market
2. Global CANCER BIOMARKERS Market - Executive Summary
2.1. Global CANCER BIOMARKERS Market Summary & Snapshot
2.2. Global CANCER BIOMARKERS Market, By Biomarkers Type (US$ Million)
2.3. Global CANCER BIOMARKERS Market, By Cancer Type (US$ Million)
2.4. Global CANCER BIOMARKERS Market, By Profiling Technologies (US$ Million)
2.5. Global CANCER BIOMARKERS Market, By Geography (US$ Million)
2.6. Global CANCER BIOMARKERS Market Outlook & Future Opportunities
3. CANCER BIOMARKERS Market Trends, Outlook, and Factors Analysis
3.1. Global CANCER BIOMARKERS Market Industry Development Trends under COVID-19 Outbreak
3.1.1. Global COVID-19 Status Overview
3.1.2. Influence of COVID-19 Outbreak on Global CANCER BIOMARKERS Market Industry Development
3.1.3. Pre & Post COVID-19 Trends and Scenarios
3.2. CANCER BIOMARKERS Market Dynamics (Growth Impacting Factors & Rationales)
3.2.1. Drivers
3.2.1.1. Rising technological advancements in the development of cancer biomarkers
3.2.1.2. Increasing incidence of cancer worldwide
3.2.1.3. Increasing use of cancer biomarkers in drug discovery & development
3.2.2. Restraints
3.2.2.1. Technical issues related to sample collection and storage
3.2.2.2. High capital investments and extensive timelines for the development of cancer biomarkers
3.2.3. Opportunities
3.2.3.1. Increased recognition of personalized medicine
3.2.3.2. Growing application areas of companion diagnostics
3.2.4. Impact Analysis of Drivers and Restraints
3.3. Ecosystem/ Value Chain Analysis
3.4. Porters Five Forces Analysis
3.5. SWOT Analysis
3.6. PEST Analysis
3.7. Average Selling Prices and Pricing Trends Analysis of CANCER BIOMARKERS Market
3.8. Technological Roadmap
3.9. Key Investment Pockets of CANCER BIOMARKERS Market
3.9.1. By Biomarkers Type
3.9.2. By Cancer Type
3.9.3. By Profiling Technologies
3.9.4. By Application
3.9.5. By Regions
4. Global CANCER BIOMARKERS Market: Estimates & Historic Trend Analysis (2020 to 2021)
4.1. Global CANCER BIOMARKERS Market, 2020 2021 (US$ Million)
4.2. Global CANCER BIOMARKERS Market, By Biomarkers Type, 2020 to 2021 (US$ Million)
4.3. Global CANCER BIOMARKERS Market, By Cancer Type, 2020 to 2021 (US$ Million)
4.4. Global CANCER BIOMARKERS Market, By Profiling Technologies, 2020 to 2021 (US$ Million)
4.5. Global CANCER BIOMARKERS Market, By Application, 2020 to 2021 (US$ Million)
4.6. Global CANCER BIOMARKERS Market, By Region, 2020 to 2021 (US$ Million)
5. Global CANCER BIOMARKERS Market Estimates & Forecast Trend Analysis, by Biomarkers Type
5.1. Global CANCER BIOMARKERS Market Share (%) Estimates and Forecasts, by Biomarkers Type, 2022 & 2033
5.2. Global CANCER BIOMARKERS Market Revenue (US$ Million) Estimates and Forecasts, by Biomarkers Type, 2022 to 2033
5.2.1. Protein Biomarkers
5.2.2. Genetic Biomarkers
5.2.3. Other Cancer Biomarkers
6. Global CANCER BIOMARKERS Market Estimates & Forecast Trend Analysis, by Cancer Type
6.1. Global CANCER BIOMARKERS Market Share (%) Estimates and Forecasts, by Cancer Type, 2022 & 2033
6.2. Global CANCER BIOMARKERS Market Revenue (US$ Million) Estimates and Forecasts, by Cancer Type, 2022 to 2033
6.2.1. Breast Cancer
6.2.2. Lung Cancer
6.2.3. Colorectal Cancer
6.2.4. Prostate Cancer
6.2.5. Melanoma
6.2.6. Leukemia
6.2.7. Thyroid Cancer
6.2.8. Bladder Cancer
6.2.9. Non-Hodgkin's Lymphoma
6.2.10. Kidney Cancer
6.2.11. Other Cancer Types
7. Global CANCER BIOMARKERS Market Estimates & Forecast Trend Analysis, by Profiling Technologies
7.1. Global CANCER BIOMARKERS Market Share (%) Estimates and Forecasts, by Profiling Technologies, 2022 & 2033
7.2. Global CANCER BIOMARKERS Market Revenue (US$ Million) Estimates and Forecasts, by Profiling Technologies, 2022 to 2033
7.2.1. Omics Technologies
7.2.2. Imaging Technologies
7.2.3. Immunoassay
7.2.4. Bioinformatics
7.2.5. Cytogenetics
Global CANCER BIOMARKERS Market Estimates & Forecast Trend Analysis, by Application
7.3. Global CANCER BIOMARKERS Market Share (%) Estimates and Forecasts, by Application, 2022 & 2033
7.4. Global CANCER BIOMARKERS Market Revenue (US$ Million) Estimates and Forecasts, by Application, 2022 to 2033
7.4.1. Diagnostics
7.4.2. Research & Development
7.4.3. Prognostics
7.4.4. Risk Assessment
7.4.5. Other Applications
8. Global CANCER BIOMARKERS Market Analysis and Forecast, by Region
8.1. Global CANCER BIOMARKERS Market Share (%) Estimates and Forecasts, by Region, 2022 & 2033
8.2. Global CANCER BIOMARKERS Market Revenue (US$ Million) Estimates and Forecasts, by Region, 2022 to 2033
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Middle East and Africa
8.2.5. Latin America
9. North America CANCER BIOMARKERS Market: Estimates & Forecast Trend Analysis
9.1. North America CANCER BIOMARKERS Market Assessments & Key Findings
9.2. North America CANCER BIOMARKERS Market Share (%) Estimates and Forecasts, 2022 & 2033
9.3. North America CANCER BIOMARKERS Market Size Estimates and Forecast (US$ Million) (2022 to 2033)
9.3.1. By Biomarkers Type
9.3.2. By Cancer Type
9.3.3. By Profiling Technologies
9.3.4. By Application
9.3.5. By Major Country
9.3.5.1. The U.S.
9.3.5.2. Canada
10. Europe CANCER BIOMARKERS Market: Estimates & Forecast Trend Analysis
10.1. Europe CANCER BIOMARKERS Market Assessments & Key Findings
10.2. Europe CANCER BIOMARKERS Market Share (%) Estimates and Forecasts, 2022 & 2033
10.3. Europe CANCER BIOMARKERS Market Size Estimates and Forecast (US$ Million) (2022 to 2033)
10.3.1. By Biomarkers Type
10.3.2. By Cancer Type
10.3.3. By Profiling Technologies
10.3.4. By Application
10.3.5. By Major Country
10.3.5.1. Germany
10.3.5.2. The U.K.
10.3.5.3. France
10.3.5.4. Italy
10.3.5.5. Spain
10.3.5.6. Rest of Europe (includes all other European countries)
11. Asia Pacific CANCER BIOMARKERS Market: Estimates & Forecast Trend Analysis
11.1. Asia Pacific CANCER BIOMARKERS Market Assessments & Key Findings
11.2. Asia Pacific CANCER BIOMARKERS Market Share (%) Estimates and Forecasts, 2022 & 2033
11.3. Asia Pacific CANCER BIOMARKERS Market Size Estimates and Forecast (US$ Million) (2022 to 2033)
11.3.1. By Biomarkers Type
11.3.2. By Cancer Type
11.3.3. By Profiling Technologies
11.3.4. By Application
11.3.5. By Major Country
11.3.5.1. China
11.3.5.2. Japan
11.3.5.3. India
11.3.5.4. ASEAN
11.3.5.5. South Korea
11.3.5.6. Rest of Asia Pacific (includes all other Asia Pacific countries)
12. Middle East & Africa CANCER BIOMARKERS Market: Estimates & Forecast Trend Analysis
12.1. Middle East & Africa CANCER BIOMARKERS Market Assessments & Key Findings
12.2. Middle East & Africa CANCER BIOMARKERS Market Share (%) Estimates and Forecasts, 2022 & 2033
12.3. Middle East & Africa CANCER BIOMARKERS Market Size Estimates and Forecast (US$ Million) (2022 to 2033)
12.3.1. By Biomarkers Type
12.3.2. By Cancer Type
12.3.3. By Profiling Technologies
12.3.4. By Application
12.3.5. By Major Country
12.3.5.1. GCC
12.3.5.2. South Africa
12.3.5.3. Egypt
12.3.5.4. Rest of Middle East & Africa (includes all other Middle East & Africa countries)
13. Latin America CANCER BIOMARKERS Market: Estimates & Forecast Trend Analysis
13.1. Latin America Market Assessments & Key Findings
13.2. Latin America CANCER BIOMARKERS Market Share (%) Estimates and Forecasts, 2022 & 2033
13.3. Latin America CANCER BIOMARKERS Market Size Estimates and Forecast (US$ Million) (2022 to 2033)
13.3.1. By Biomarkers Type
13.3.2. By Cancer Type
13.3.3. By Profiling Technologies
13.3.4. By Application
13.3.5. By Major Country
13.3.5.1. Brazil
13.3.5.2. Mexico
13.3.5.3. Rest of Latin America (includes all other Latin America countries)
14. Competitive Landscape
14.1. CANCER BIOMARKERS Market Revenue Share Analysis (%), by Major Players (2021)
14.2. CANCER BIOMARKERS Market Competition Matrix, by Leading Players
14.3. CANCER BIOMARKERS List of Emerging, Prominent and Leading Players
14.4. Major Mergers & Acquisitions, Partnership, Joint Venture, Expansions, Deals, Recent Developments, etc.
15. Company Profiles
15.1. Abbott Laboratories
15.1.1. Company Overview & Insights
15.1.2. Financial Performance
15.1.3. Product / Service Portfolio
15.1.4. Geographical Footprint & Share
15.1.5. Strategic Initiatives & Key Developments
*Similar details would be provided for all the players mentioned below
15.2. Bio-rad laboratories, Inc.
15.3. Bristol-Myers Squibb (BMS) Company
15.4. EXACT Sciences Corporation
15.5. Merck KGaA
15.6. PerkinElmer, inc.
15.7. Qiagen N.V.
15.8. Roche Holding AG
15.9. Siemens AG
15.10. Thermo Fisher Scientific, Inc.
15.11. Others
16. Assumptions and Research Methodology
16.1. Data Mining
16.2. Secondary Research
16.3. Primary Research
16.4. Subject Matter Expert Advice
16.5. Quality Check
16.6. Final Review
16.7. Data Triangulation
16.8. Bottom-Up Approach
16.9. Top Down Approach
16.10. Research Flow
16.11. Key Insights from Industry Experts
16.12. Data Sources
16.13. Assumptions
16.14. Limitations
17. Conclusions and Recommendations
17.1. Key Research Findings and Conclusion
17.2. Key Insights & Recommendations from Analysts